Tuberculosis Treatment Outcome in Patients with TB-HIV Coinfection in Kuala Lumpur, Malaysia

Table 4

Significant determinant factors of TB treatment outcomes in patients with TB-HIV in Kuala Lumpur, the final model (total patients, n = 235).

Characteristic	SLR				MLR
	Unadjusted OR	95% CI	χ^2 (df)^a	value	aOR^c	95% CI	χ^2 (df)^a	value
DOTS status
No	35.78	15.99, 80.05	117.221 (1)	<0.001	21.71	5.36, 87.94	24.52 (1)	<0.001
Yes	1	—	—	—	1	—	—	—
Duration of TB treatment (months)			206.98 (2)	<0.001
<6	79.05	15.90, 393.03	28.52 (1)^b	<0.001	34.54	5.97, 199.93	15.63 (1)^b	<0.001
6–12	0.31	0.05, 1.84	1.66 (1)^b	0.198	0.19	0.03, 1.38	2.72 (1)^b	0.099
≥12	1	—	—	—	1	—	—	—

^aLikelihood ratio (LR) test. ^bWald test. ^cAdjusted for citizenship status, ethnicity, formal education, employment status, household income, BCG scar, ART, CXR upon diagnosis, sputum culture upon diagnosis, DOTS status, and duration of TB treatment using the forward LR method. . There was no multicollinearity (VIF <10) and no interaction problem. 1, reference; SLR, simple logistic regression; MLR, multiple logistic regression; OR, odds ratio; aOR, adjusted odds ratio; df, degree of freedom.